CF PharmTech
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
J-park no.99 Jinxi Rd Ofc 203, Wuxi, Jia...Phone Number
+86 51286867555Website
www.cfpharmtech.comRevenue
$13.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CF PharmTech
长风药业股份有限公司 is a professional pharmaceutical company dedicated to providing high-quality inhalation drugs for the global market. The company focuses on integrated management solutions for respiratory diseases, including allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD), and other significant clinical needs. Their product line includes various inhalation formulations such as aerosol sprays, dry powder inhalers, and nasal sprays. With a strong emphasis on research and development, the company aims to address the growing demand for effective treatments in the respiratory health sector.Explore more
CF PharmTech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CF PharmTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if CF PharmTech is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at CF PharmTech
Check if CF PharmTech has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CF PharmTech has new funding data
CF PharmTech, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if CF PharmTech had a recent Job posting/layoffs
Earning: See what the market has to say on CF PharmTech recently announced quarterly report
Product Launch: Get notified when CF PharmTech launches new products
Recommended Actions
Reach out to Masked Content who joined CF PharmTech as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
CF PharmTech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CF PharmTech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CF PharmTech.
CF PharmTech financials insights
Gather financial insights about CF PharmTech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series D
$65M
2020
Series E
$90M
Series F
$50M
CF PharmTech Tech Stack
A closer look at the technologies used by CF PharmTech
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Funding
Funding
CF PharmTech has secured $90 million in Series E funding. The round was led by New Alliance Capital, with participation from CR-CP Life Science Fund, Finnova Capital, GT Capital, and others.
Funding
Funding
CF PharmTech recently secured $65 million in a Series D funding round led by Future Industry Investment Fund.
Spending/Investment, Funding
New Hire
Executive Move
Executive Moves, New Hire
CF PharmTech News & Media
CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the Commercialization of ...
/CNW/ -- CF PharmTech, Inc. ("CF PharmTech") announced today that it has raised US $50M in Series F financing following its US $90M Series E financing in...CF PharmTech Raises $90M to Advance Respiratory Drug Development
The China-based pharmaceutical company CF PharmTech has raised $90 million to support its pipeline of respiratory drugs. The Series E investment round wasCF PharmTech Raises $90M in Series E Funding
CF PharmTech, Inc., a Shuzhou, China-based pharmaceutical company, raised $90m in Series E funding. The round was led by New Alliance Capital with participation from new investors CR-CP Life Science Fund, Finnova Capital, GT Capital, Co-stone Asset Management, Xiangcheng Financial Holdings, Everest Venture Capital, and existing investors, such as Oriza Holdings, Longmen Venture Capital, GTJA […] The post CF PharmTech Raises $90M in Series E Funding appeared first on FinSMEs.CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs
SHUZHOU, China, Jan. 2, 2020 /PRNewswire/ -- CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E investment led by New Alliance Capital. The investment included...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CF PharmTech
Sign Up For FreeTo access detailed company insights
长风药业股份有限公司 is a professional pharmaceutical company dedicated to providing high-quality inhalation drugs for the global market. The company focuses on integrated management solutions for respiratory diseases, including allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD), and other significant clinical needs. Their product line i... Read More
